| [1] | Ruimin JIAO, Jingjie ZHAO, Juanjuan LI, Wei CHEN, Chaoru HAN, Li LI, Chunjun XU, Hong YOU. Quality assessment of guidelines/consensuses on traditional Chinese medicine/integrated traditional Chinese and Western medicine diagnosis and treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2025, 41(3): 446-452. doi: 10.12449/JCH250309 |
| [2] | Zhili XIAO, Chenxia LU, Danni ZHOU, Zhuangzhuang CHEN, Mingzhong XIAO, Xiaodong LI. Role of lipophagy in the prevention and treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(7): 1450-1458. doi: 10.12449/JCH240725 |
| [3] | Aiping TIAN, Yongfeng YANG. Diagnosis of nonalcoholic fatty liver disease: The importance of pathology[J]. Journal of Clinical Hepatology, 2023, 39(3): 491-497. doi: 10.3969/j.issn.1001-5256.2023.03.002 |
| [4] | Chenlu ZHAO, Cheng ZHOU, Dongfang SHANG, Sutong LIU, Junhao SHI, Xiaojie WANG, Wenxia ZHAO. Influence of white fat browning on nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(4): 909-914. doi: 10.3969/j.issn.1001-5256.2023.04.025 |
| [5] | Wenjing NI, Jie LI, Jiangao FAN. A brief introduction of AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease in 2023[J]. Journal of Clinical Hepatology, 2023, 39(5): 1049-1055. doi: 10.3969/j.issn.1001-5256.2023.05.008 |
| [6] | Xiaodong ZHOU, Na TIAN, Minghua ZHENG. Excerpt of an international multidisciplinary consensus statement on MAFLD and the risk of CVD （2023）[J]. Journal of Clinical Hepatology, 2023, 39(10): 2336-2339. doi: 10.3969/j.issn.1001-5256.2023.10.010 |
| [7] | Weihong LIU, Hui LIU, Huiguo DING, Lei LI. Clinical characteristics and prognosis of patients with chronic hepatitis B combined with metabolic associated fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(10): 2230-2235. doi: 10.3969/j.issn.1001-5256.2022.10.007 |
| [8] | Cong TONG, Yanian LI, Da GU, Xiang'an ZHAO, Xiaoxing XIANG. The association between obesity measurement indices and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2465-2468. doi: 10.3969/j.issn.1001-5256.2021.10.044 |
| [9] | Xiangqian HUANG, Xiaomeng YAN, Mingda ZHANG, Jing WU, Jianhong CHEN. Association between nonalcoholic fatty liver disease and colorectal neoplasms[J]. Journal of Clinical Hepatology, 2021, 37(12): 2947-2950. doi: 10.3969/j.issn.1001-5256.2021.12.045 |
| [10] | Jiahe ZHAO, Xinyu MA, Jingya XU, Tingting DUAN, Chunlei ZHANG, Baolong LI. Research advances in related factors for autophagy in the regulation of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(7): 1713-1717. doi: 10.3969/j.issn.1001-5256.2021.07.050 |
| [11] | Luying ZHU, Yuchen LI, Lihua DENG, Jingtong WANG. Research advances in extrahepatic diseases associated with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(9): 2215-2219. doi: 10.3969/j.issn.1001-5256.2021.09.043 |
| [12] | Yao ChengZi, Feng Gong, Yu WenSi, Du Huan, Mi Man. Risk factors for the development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(2): 433-436. doi: 10.3969/j.issn.1001-5256.2020.02.044 |
| [13] | Xue Rui, Fan JianGao. Brief introduction of an international expert consensus statement: A new definition of metabolic associated fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(6): 1224-1227. doi: 10.3969/j.issn.1001-5256.2020.06.007 |
| [14] | FENG Gong, YAN QinQin, HE Na, MI Man. From nonalcoholic fatty liver disease to metabolic fatty liver disease:An analysis based on disease heterogeneity[J]. Journal of Clinical Hepatology, 2020, 36(11): 2597-2600. doi: 10.3969/j.issn.1001-5256.2020.11.045 |
| [15] | Zhao LiQiong, Li LiangPing. Independent association between sarcopenia and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(6): 1377-1379. doi: 10.3969/j.issn.1001-5256.2019.06.044 |
| [16] | Chu PeiLing, Wang Qi, Guo XiaoQing, Liu JinChun. Association between chemokines and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(7): 1626-1628. doi: 10.3969/j.issn.1001-5256.2019.07.044 |
| [17] | Chinese Society of EndocrinologyChinese Medical Association. Consensus for diagnosis and treatment of nonalcoholic fatty liver diseases and metabolic disorders (2nd Edition)[J]. Journal of Clinical Hepatology, 2018, 34(10): 2103-2108. doi: 10.3969/j.issn.1001-5256.2018.10.010 |
| [18] | Feng Gong, Niu ChunYan. Advances in the treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2433-2438. doi: 10.3969/j.issn.1001-5256.2017.12.041 |
| [19] | Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on TCM diagnosis and treatment of nonalcoholic fatty liver disease (2017)[J]. Journal of Clinical Hepatology, 2017, 33(12): 2270-2274. doi: 10.3969/j.issn.1001-5256.2017.12.002 |
| [20] | Guo YinYan, Li Peng. A study on the role of serum Retinol Binding Protein 4 in nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2012, 28(4): 279-280+301. |
DownLoad: